HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 242 filers reported holding HORIZON PHARMA PLC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $5,000 | -80.0% | 233 | -82.1% | 0.00% | -100.0% |
| Q3 2018 | $25,000 | – | 1,301 | +7127.8% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 18 | -82.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -96.6% | 100 | -94.9% | 0.00% | -100.0% |
| Q1 2017 | $29,000 | -9.4% | 1,945 | -2.2% | 0.00% | -50.0% |
| Q4 2016 | $32,000 | -11.1% | 1,989 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $36,000 | -56.6% | 1,995 | -60.3% | 0.00% | -60.0% |
| Q2 2016 | $83,000 | +62.7% | 5,028 | +111.6% | 0.01% | +66.7% |
| Q4 2015 | $51,000 | – | 2,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scale Management, LLC | 1,710,451 | $59,421,000 | 38.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,259,875 | $425,908,000 | 14.19% |
| Broadfin Capital, LLC | 4,815,807 | $167,301,000 | 8.99% |
| JW Asset Management, LLC | 766,724 | $26,636,000 | 8.10% |
| Marble Arch Investments | 1,888,000 | $65,589,000 | 5.65% |
| HealthCor Management, L.P. | 3,200,000 | $111,168,000 | 5.60% |
| Beach Point Capital Management LP | 794,290 | $27,594,000 | 5.42% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,325,829 | $115,539,000 | 4.52% |
| Ratan Capital Management LP | 1,321,300 | $45,902,000 | 4.37% |
| Green Owl Capital Management, LLC | 130,000 | $4,516,000 | 3.22% |